
|Videos|February 16, 2023
Case 3: Faricimab in a neovascular nAMD patient with persistent fluid
Advertisement
Dr. Khanani discusses how switching to faricimab helped resolve persistent intraretinal and subretinal fluid in a patient and extended treatment intervals leading to decreased patient burden.
Sponsored by Roche
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
The Retina TL;DR with Dr. Weng: Navigating the ocular risks of facial fillers with Jennifer Murdock, MD
2
Retina World Congress 2026: Can vibration reduce pain during intravitreal injections?
3
Retina World Congress 2026: Sunir J. Garg, MD, FACS, on preventing occupational injury in retina practice
4
Retina World Congress 2026: Diagnosing macular telangiectasia in a field of mimickers
5




















